elastase inhibitors (NAEJA)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameelastase inhibitors (NAEJA)
Drug Alias NameSYN-1134SYN-1396SYN-1360SYN-1389SYN-1386 +[6] 
ClassificationSmall molecules
Mechanisms of ActionLeukocyte elastase inhibitors
TargetsLeukocyte elastase
Therapy Area/IndicationsEmphysemaRespiratory Distress Syndrome, AdultCystic Fibrosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNaeja Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNaeja Pharmaceutical Inc
Active IndicationsN/A
Inactive IndicationsEmphysemaRespiratory Distress Syndrome, AdultCystic Fibrosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A